RMRenata R. Mukhametova

Renata R. Mukhametova

*This is an algorithmically generated author record based on publicly available information.

Renata R. Mukhametova has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Treatment optimization for iron deficiency anemia in pregnant women as a resource to prevent perinatal complications

    by T. P. Zefirova, R. R. Mukhametova, E. Iu. Iupatov, A. T. Khaertdinov

    Treatment optimization for iron deficiency anemia in pregnant women as a resource to prevent perinatal complications


  • Pharmacoepidemiologic features of iron deficiency anemia in obstetric and gynecologic practice and clinical and economic feasibility of using ferric carboxymaltose for its correction

    by S.V. Nedogoda, A.S. Salasyuk, T.P. Zefirova, A.N. Drobinskaya, R.R. Mukhametova, I.M. Davydov, M.N. Umansky, M.K. Bartsits

    Aim. To assess the impact of iron deficiency conditions on pregnancy and its outcomes based on the analysis of real clinical practice data, and to determine the economic feasibility of timely correction of iron deficiency anaemia (IDA) in pregnant women with modern iron preparations. Material and methods. Within the framework of this study, we analyzed the primary documentation of 440 patients observed in three regions of the Russian Federation. The peculiarities of the course and management of pregnancy and its outcomes in patients depending on the presence and severity of iron deficiency (ID) were analyzed. We evaluated the cost-effectiveness of diagnostics and correction of IDA ferric carboxymaltose in the presence of indications, taking into account its effect on the cost of in-hospital therapy for complicated pregnancy, blood transfusions, and the patient’s stay in the intensive care unit (ICU). Results. The mean age of the pregnant women was 29 years (95% CI 25 to 33 years), and 30.9% were diagnosed with anaemia in the first trimester of pregnancy. At the time of discharge after delivery, 55.5% of the patients had unadjusted IDA: the median haemoglobin at discharge was less than 100 g/l. An analysis of diagnostic approaches to the detection of IDA showed that diagnosis is based only on haemoglobin levels, and ferritin levels were determined in a limited number of patients. Of those admitted for delivery with a diagnosis of anaemia, in 22.5% of cases it was recorded throughout all three trimesters. Anaemia of moderate severity was diagnosed in 11% of pregnant women and severe anaemia in 3%, with Hb concentration below 100 g/l in 58.3% of women immediately before delivery. It has been shown that IDA is a risk factor for complicated pregnancy, threatened termination of pregnancy, complications of labour and postpartum haemorrhage, and is associated with a higher frequency of perinatal haemotransfusions. The duration of hospitalisation was statistically significantly longer in the presence of severe anaemia, and the length of stay in the ICU was longer in the presence of severe and moderate anaemia. Adequate correction of anaemia resulted in a 12.4% reduction in the risk of threatened termination of pregnancy, while the use of ferric carboxymaltose resulted in a statistically significant 11.1% (95% CI –0.016; –0.206) reduction in the risk of postpartum haemorrhage and a 13.8% (95% CI –0.044; –0.232) reduction in the volume of blood loss. Adequate prenatal correction of severe IDA in 100 patients will reduce the need for postpartum transfusions, the duration of stay in hospital and ICU, as well as the frequency of hospitalisations due to complicated pregnancy, thus eliminating additional healthcare costs by RUB 2.74 million. These savings fully cover the cost of adequate diagnosis and treatment of IDA. Conclusion. The actual practice of management of patients with iron deficiency anaemia differs significantly from clinical recommendations. The problem of iron deficiency anaemia in pregnant and postpartum women, its adverse impact on the course and outcomes of pregnancy, clinical inertness, use of irrational drugs for correction, such as iron preparations for intramuscular administration, and deficiencies in diagnostic approaches to detecting this condition are still acutely relevant. Adequate and timely correction of iron deficiency anaemia not only leads to improved clinical outcomes of pregnancy but is also a cost-effective technology that helps to reduce the costs of the health care system.


  • Open Access

    Clinical observation of delivery in a COVID-19-convalescent woman with preeclampsia developing fetal distress during preterm labor

    by E. Iu. Iupatov, A. T. Khaertdinov, S. A. Osipov, E. E. Selivanova, R. R. Mukhametova

    The course of the pandemic revealed that despite the general populational risks for developing novel coronavirus infection (NCI) COVID-19, pregnant women are more susceptible to its severe course and unfavorable perinatal outcomes. Currently, NCI is associated with a high risk of spontaneous miscarriages, premature rupture of fetal membranes, preterm delivery, development of fetoplacental insufficiency, fetal growth retardation, fetal distress, exacerbation of chronic somatic pathology, and postpartum bleeding. A brief literature review and the described clinical case demonstrate a need to thoroughly examine puerperal women with preterm delivery.


  • Open Access

    Experience of the combined use of iron and folic acid preparations for the correction of latent iron deficiency in the clinical practice of an obstetrician-gynecologist. Clinical case

    by Tatiana P. Zefirova, Renata R. Mukhametova, Albert T. Khaertdinov, Enzhe M. Garipova

    Iron deficiency anemia is widespread among the female population. Pregnant women are a particularly vulnerable group, because the existing iron reserves are inadequate, and during pregnancy the need for iron for the formation of the placenta and fetal growth increases sharply, as a result, there is an imbalance between the intake and consumption of this trace element. Anemia increases the risks of various complications of gestation and multiplies maternal mortality. Note an increase in the frequency of premature childbirth, the threat of termination of pregnancy, placental insufficiency, weakness of labor, fetal development delay, fetal hypoxia, low birth weight of the newborn, the volume of pathological blood loss during childbirth and in the early postpartum period. At the same time, the development of these pathological conditions can be prevented by following modern protocols of pre-pregnancy preparation and pregnancy management. Prevention of anemia includes the use of various iron preparations, as well as new combinations, in particular a combination of 80 mg of elemental iron and 350 mcg of folic acid. In the article, we describe clinical cases demonstrating a rational preventive approach that prevents the development of clinical anemia and promotes safe perinatal outcomes for mother and fetus.

  • Open Access

    What is the Danger of Psychological Stress for Pregnant Women and How to Reduce its Impact on the Course of Pregnancy and Perinatal Outcomes

    by Kazan State Medical Academy, T.P. Zefirova, Russian Federation Kazan, R.R. Mukhametova

    Aim: assess the impact of psycho-emotional stress on the course of pregnancy at various times, as well as consider the possibility of reducing it with the help of vitamin-mineral complexes. Key Points. Pregnant women, like all others, are influenced by a variety of stress factors, and about 30% of them at different stages of gestation realize clinical manifestations of psychological stress. The article considers issue related to the causes of psychological stress before and during pregnancy, identifies the most vulnerable categories of women. Data on the influence of psychological stress on pregnancy outcomes and postnatal development are presented. Attention is paid to modern ideas about the pathogenesis of the damaging effect of psychological stress on various body systems, including the microbiome. Emphasis is placed on the role of an obstetrician-gynecologist as an attending physician in the timely identification of women with signs of psychological stress, in the organization of non-drug care and rational pharmacological support. Pathogenetically justified possibilities of using vitamin and mineral complexes to compensate for the negative effects of psychological stress at the preconception stage and during pregnancy were discussed. Conclusion. Stress before and during pregnancy affects the offspring in the long term, disrupting their physical condition, negatively affecting the functions of the central nervous system. In modern obstetric practice, medical alertness, timely consultation with specialists and the full use of all the possibilities of non-drug and pharmacological support aimed at overcoming anxiety and stress at each stage of gestation will be relevant. Key words: psychological stress, pregnancy, perinatal complications, anemia, vitamin and mineral complexes.


  • Open Access

    Umbilical cord vascular thrombosis: literature review and two clinical cases

    by E. Iu. Iupatov, T. E. Kurmanbaev, I. R. Galimova, A. T. Khaertdinov, R. R. Mukhametova, A. L. Mirolyubov, D. N. Ablaeva, A. M. Khromova, M. I. Timerzyanov, M. D. Leonova

    Thrombosis of the umbilical cord vessels is a rare complication of pregnancy, combined with a high level of perinatal morbidity and mortality. Anomalies of vascular attachment (velamentous attachment), pathology of the umbilical cord (hyperspiralization, short or long umbilical cord), intrauterine infections, maternal diabetes mellitus and preeclampsia as well as meconium found in the amniotic fluid are among the risk factors of developing thrombosis in the umbilical cord vessels. Here we present two clinical observations of umbilical vein thrombosis at full-term pregnancy. In both cases, during pregnancy and childbirth, no signs of umbilical cord pathology were found according to cardiotocography and Doppler ultrasound; despite this, the children were born in hypoxic state. Both newborns were transferred to the second stage of treatment due to suspected intrauterine pneumonia. Velamentous attachment, intrauterine infections as well as meconium found in the amniotic fluid were the risk factors of developing umbilical vein thrombosis described in case 1 and case 2, respectively. During pregnancy, both female patients suffered from clinically confirmed novel coronavirus infection (COVID-19) and contacted patients with COVID-19 in the third trimester of gestation. It is likely that endothelial damage caused by the novel coronavirus SARS-CoV-2 was one of the risk factors for the development of umbilical vein thrombosis, but this issue requires to be further explored.